Pay in 4 interest-free payments of $5.50 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Tirzepatide, also known as Mounjaro, is already approved and available, while Mazdutide is still in the clinical trial phase
Whilst some blood glucose improvements may appear within the first week, the medication reaches steady-state concentrations after 4 to 5 weeks, with maximal glycaemic effects typically observed over 3 to 6 months following dose titration
- Production date is indicated on the packaging
Viking Therapeutics (VKTX), the developer of a promising experimental weight-loss drug, has announced a multi-year partnership with CordenPharma, a leading contract manufacturing firm
Tirzepatide is FDA-approved (as both Mounjaro and Zepbound), which places it in a more favorable category than unapproved compounds
PLEASE NOTE: The information provided on this page is intended for general informational purposes only
US$ 20.39
US$ 28.86
US$ 28.66
US$ 26.37
US$ 20.31
